Acupuncture may slash opioid use in cancer patients

NCT ID NCT04459416

Ongoing Symptom relief Sponsor: Memorial Sloan Kettering Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding acupuncture to standard pain care can reduce the need for strong opioid painkillers in people with multiple myeloma, Hodgkin disease, or non-Hodgkin lymphoma who are getting high-dose chemotherapy. About 299 adults will be randomly assigned to receive either usual pain management alone or usual care plus acupuncture. The goal is to see if acupuncture helps control pain and other symptoms, and improves quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HODGKIN DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia classic Hodgkin lymphoma Hodgkins lymphoma non-Hodgkin lymphoma plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HODGKIN DISEASE MULTIPLE MYELOMA NON-HODGKIN LYMPHOMA

Contacts and locations

Locations

Fred Hutchinson Cancer Research Center

Seattle, Washington, 98109, United States
Memorial Sloan Kettering Cancer Center

New York, New York, 10065, United States
Seattle Cancel Care Alliance (Data Collection Only)

Seattle, Washington, 98109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.